PRMT5 and hepatocellular carcinoma: As a prognostic biomarker of HCC [6], protein arginine methyltransferase 5 (PRMT5) has been proven to be an essential epigenetic regulator for regulating cell proliferation and apoptosis by methylation of arginine residues [7].